pn 202-791 has been researched along with cadmium in 2 studies
Studies (pn 202-791) | Trials (pn 202-791) | Recent Studies (post-2010) (pn 202-791) | Studies (cadmium) | Trials (cadmium) | Recent Studies (post-2010) (cadmium) |
---|---|---|---|---|---|
44 | 0 | 1 | 37,999 | 84 | 18,071 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hammond, C; Henderson, G; Mason, WT; Morton, AJ | 1 |
Dooley, DJ; Hertting, G; Lupp, A; Osswald, H | 1 |
2 other study(ies) available for pn 202-791 and cadmium
Article | Year |
---|---|
Characterisation of the L- and N-type calcium channels in differentiated SH-SY5Y neuroblastoma cells: calcium imaging and single channel recording.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Cadmium; Cadmium Chloride; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Differentiation; Cell Line; Cell Membrane; Chlorides; Evoked Potentials; Fura-2; Humans; Kinetics; Microscopy, Fluorescence; Neuroblastoma; Nicotinic Acids; Nifedipine; omega-Conotoxins; Oxadiazoles; Peptides, Cyclic; Potassium; Tretinoin | 1992 |
Omega-conotoxin GVIA and pharmacological modulation of hippocampal noradrenaline release.
Topics: Aminopyridines; Animals; Brimonidine Tartrate; Cadmium; Calcium Channel Blockers; Dioxanes; Hippocampus; Idazoxan; In Vitro Techniques; Mollusk Venoms; Neomycin; Nicotinic Acids; Norepinephrine; omega-Conotoxin GVIA; Oxadiazoles; Phorbol Esters; Quinoxalines; Rabbits | 1988 |